相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Mechanism of Amyloid Fibril Formation
Oxana Galzitskaya
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
Ting Yang et al.
ANNALS OF NEUROLOGY (2019)
N-Terminal Truncated A beta(4-42) Is a Substrate for Neprilysin Degradation in vitro and in vivo
Karen Hornung et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Studies of the Process of Amyloid Formation by Aβ Peptide
O. V. Galzitskaya et al.
BIOCHEMISTRY-MOSCOW (2018)
To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide
Olga M. Selivanova et al.
LANGMUIR (2018)
Femtosecond X-ray coherent diffraction of aligned amyloid fibrils on low background graphene
Carolin Seuring et al.
NATURE COMMUNICATIONS (2018)
Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by A beta Peptide and Its Fragments
Oxana Galzitskaya et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease
Joyce Tran et al.
FEBS LETTERS (2017)
Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis
Oxana V. Galzitskaya et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization
Nathan G. Glasgow et al.
JOURNAL OF NEUROSCIENCE (2017)
Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures
Lu Fu et al.
JOURNAL OF PEPTIDE SCIENCE (2017)
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy
Lothar Gremer et al.
SCIENCE (2017)
Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity
Tien-Wei Lin et al.
PLOS ONE (2017)
Determination of regions involved in amyloid fibril formation for Aβ(1-40) peptide
A. K. Surin et al.
BIOCHEMISTRY-MOSCOW (2016)
Peptide Aβ(16-25) forms nanofilms in the process of its aggregation
O. M. Selivanova et al.
BIOCHEMISTRY-MOSCOW (2016)
The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide
Olga M. Selivanova et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42
Nikita V. Dovidchenko et al.
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril
Marielle Aulikki Walti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
X-ray diffraction and electron microscopy data for amyloid formation of Aβ40 and Aβ42
Olga M. Selivanova et al.
DATA IN BRIEF (2016)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Combining an amyloid-beta (A beta) cleaving enzyme inhibitor with a gamma-secretase modulator results in an additive reduction of A beta production
Kia Stromberg et al.
FEBS JOURNAL (2015)
Studies of Polymorphism of Amyloid-beta(42) Peptide from Different Suppliers
Mariya Yu. Suvorina et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease
Kazuma Murakami
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2014)
Activation of Neuronal Defense Mechanisms in Response to Pathogenic Factors Triggering Induction of Amyloidosis in Alzheimer's Disease
Alexander V. Maltsev et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1-42 Molecular Assembly
Massimo Messa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
How to Determine the Size of Folding Nuclei of Protofibrils from the Concentration Dependence of the Rate and Lag-Time of Aggregation. I. Modeling the Amyloid Protofibril Formation
Nikita V. Dovidchenko et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Riqiang Yan et al.
LANCET NEUROLOGY (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
beta-arrestin 2 regulates A beta generation and gamma-secretase activity in Alzheimer's disease
Amantha Thathiah et al.
NATURE MEDICINE (2013)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
Chris G. Parsons et al.
NEUROTOXICITY RESEARCH (2013)
High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors
Karthikeyan Muthusamy et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2013)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
The role of β-amyloid peptide in neurodegenerative diseases
A. V. Maltsev et al.
AGEING RESEARCH REVIEWS (2011)
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
Shalini John et al.
BMC BIOINFORMATICS (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Recent progress in understanding Alzheimer's β-amyloid structures
Marcus Faendrich et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence
Sergiy O. Garbuzynskiy et al.
BIOINFORMATICS (2010)
Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid β-Protein Assembly and Toxicity
Kenjiro Ono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Marwa Aboukhatwa et al.
MOLECULAR NEURODEGENERATION (2010)
Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease
Gen He et al.
NATURE (2010)
Structural polymorphism of Alzheimer Aβ and other amyloid fibrils
Marcus Fändrich et al.
Prion (2010)
A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
Giuseppe Di Fede et al.
SCIENCE (2009)
Structural Polymorphism of 441-Residue Tau at Single Residue Resolution
Marco D. Mukrasch et al.
PLOS BIOLOGY (2009)
A new amyloid μ variant favoring oligomerization in Alzheimer's-type dementia
Takami Tomiyama et al.
ANNALS OF NEUROLOGY (2008)
Flavonols and flavones as BACE-1 inhibitors: Structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features
Yoshiari Shimmyo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease
C Ballard et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Cholinesterase inhibitors for Alzheimer's disease
J Birks
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Discovery of cell-permeable non-peptide inhibitors of β-secretase by high-throughput docking and continuum electrostatics calculations
DZ Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibitors of γ-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21
LM Minter et al.
NATURE IMMUNOLOGY (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease
C Schmitz et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease
CJ Lu et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Early onset familial Alzheimer's disease - Mutation frequency in 31 families
JC Janssen et al.
NEUROLOGY (2003)
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation
M Fändrich et al.
EMBO JOURNAL (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Induction of neuronal death by α-synuclein
AR Saha et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
